Black Rock Inc. Catalent, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 15,354,327 shares of CTLT stock, worth $975 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,354,327
Previous 15,196,647
1.04%
Holding current value
$975 Million
Previous $858 Million
0.64%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding CTLT
# of Institutions
57Shares Held
16.8MCall Options Held
10.7KPut Options Held
53.4K-
Segantii Capital Management LTD250KShares$15.9 Million1.75% of portfolio
-
Credit Suisse Ag Zurich, V8210KShares$13.3 Million0.01% of portfolio
-
Eaton Vance Management Boston, MA189KShares$12 Million0.02% of portfolio
-
Eisler Capital (Uk) Ltd. London, X0165KShares$10.5 Million0.05% of portfolio
-
Barclays PLC London, X0117KShares$7.42 Million0.0% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $11.4B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...